Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2025)

Camp4 Therapeutics' Interest & Investment Income history spans 3 years, with the latest figure at $710000.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 16.39% year-over-year to $710000.0; the TTM value through Dec 2025 reached $2.2 million, up 63.46%, while the annual FY2025 figure was $2.2 million, 63.46% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $710000.0 at Camp4 Therapeutics, up from $423000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $710000.0 in Q4 2025 and bottomed at $94000.0 in Q3 2024.
  • The 3-year median for Interest & Investment Income is $453000.0 (2025), against an average of $465888.9.
  • The largest annual shift saw Interest & Investment Income plummeted 86.36% in 2024 before it soared 350.0% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at $689000.0 in 2023, then fell by 11.47% to $610000.0 in 2024, then grew by 16.39% to $710000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Interest & Investment Income are $710000.0 (Q4 2025), $423000.0 (Q3 2025), and $453000.0 (Q2 2025).